Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

277
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
277
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

423
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
423
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

567
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
567
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

593
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
593
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.5K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

407
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
407

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Forced osteoarthritis therapy: expanding the scope of the possible].

Khirurgiia·2018
Same author

[Ormond's disease complicated by infectious endocarditis].

Klinicheskaia meditsina·2015
Same author

[Comparative efficacy of infliximab and adalimumab in patients with rheumatoid arthritis].

Klinicheskaia meditsina·2014
Same author

[Functionally sparing operation in locally advanced laryngeal cancer].

Vestnik otorinolaringologii·2005
Same author

[Rhabdomyosarcoma of the ethmoid bone].

Vestnik otorinolaringologii·2002
Same author

[A trial of the use of low-molecular-weight heparin (fraksiparin) in myocardial infarct].

Terapevticheskii arkhiv·1996

Related Experiment Video

Updated: Feb 22, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

17.7K

NEW POSSIBILITIES FOR THE TREATMENT OF ENTEROCOCCAL INFECTIOUS ENDOCARDITIS.

V P Tyurin, V G Gudynovich, V L Volkova

    Klinicheskaia Meditsina
    |September 29, 2017
    PubMed
    Summary

    Daptomycin therapy was analyzed in 7 patients with enterococcal infectious endocarditis, with notable resistance to common antibiotics like gentamicin. This study provides insights into treatment outcomes and recommendations for managing this serious infection.

    More Related Videos

    In Vivo Mouse Model of Spinal Implant Infection
    08:03

    In Vivo Mouse Model of Spinal Implant Infection

    Published on: June 23, 2020

    2.8K
    An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
    07:50

    An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

    Published on: January 7, 2019

    7.3K

    Related Experiment Videos

    Last Updated: Feb 22, 2026

    Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
    07:46

    Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

    Published on: June 4, 2012

    17.7K
    In Vivo Mouse Model of Spinal Implant Infection
    08:03

    In Vivo Mouse Model of Spinal Implant Infection

    Published on: June 23, 2020

    2.8K
    An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
    07:50

    An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

    Published on: January 7, 2019

    7.3K

    Area of Science:

    • Infectious Diseases
    • Cardiology
    • Pharmacology

    Background:

    • Enterococcal infectious endocarditis (EIE) is a severe infection, often caused by resistant strains of Enterococcus faecium.
    • Daptomycin is an important antibiotic for treating Gram-positive bacterial infections, including EIE.
    • High rates of antibiotic resistance (gentamicin, penicillin, vancomycin) complicate EIE treatment.

    Purpose of the Study:

    • To analyze the outcomes of daptomycin therapy in patients with EIE.
    • To evaluate the effectiveness of ampicillin plus ceftriaxone for gentamicin-resistant enterococci.
    • To provide updated recommendations for the antibacterial treatment of EIE.

    Main Methods:

    • Retrospective analysis of 7 patients with EIE treated with daptomycin.
    • Assessment of antibiotic resistance profiles of Enterococcus faecium strains.
    • Review of clinical outcomes, including prosthetic valve endocarditis, surgery, and hospital lethality.

    Main Results:

    • Daptomycin therapy was administered for a mean duration of 36.7 days.
    • High resistance rates were observed: 70% to gentamicin, 40% to penicillin, and 14.3% to vancomycin.
    • Hospital lethality was 14.3%, with 28.6% of patients undergoing valve prosthetic surgery.

    Conclusions:

    • Daptomycin can be a viable option for EIE, particularly in cases with multidrug-resistant enterococci.
    • Ampicillin plus ceftriaxone shows potential for treating gentamicin-resistant enterococci.
    • Updated treatment guidelines are crucial for effective management of EIE, considering evolving resistance patterns.